Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
137.1 USD | -1.34% | +3.68% | +4.30% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.30% | 13.98B | |
-2.25% | 104B | |
+1.51% | 97.42B | |
+0.79% | 22.2B | |
-17.89% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.14% | 15.06B | |
+34.79% | 11.66B | |
-26.13% | 8.22B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Oppenheimer Adjusts Neurocrine Biosciences PT to $154 From $140, Maintains Outperform Rating